BioAvenge

BioAvenge owns genomic and proteomic technology platforms. The company incorporates technology platforms for analyzing and studying genes and gene expression, as well as biologically significant gene sequences, into gene discovery, functional analysis, and the identification of biological hazardous substances. It also utilizes its technology for target validation, screening for biological contamination, diagnostic applications, and the development of preventive and therapeutic vaccines. The company was founded in 2000 and is headquartered in Gaithersburg, Maryland. Since February 12, 2008, BioAvenge has been operating as a subsidiary of a U.S.-based online company.